Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001437749-20-025664
Filing Date
2020-12-21
Accepted
2020-12-21 09:16:42
Documents
2

Document Format Files

Seq Description Document Type Size
1 FORM 424B5 atos20201218_424b5.htm 424B5 411388
2 atos20201218_424b5img001.jpg GRAPHIC 6170
  Complete submission text file 0001437749-20-025664.txt   421066
Mailing Address 107 SPRING STREET SEATTLE WA 98104
Business Address 107 SPRING STREET SEATTLE WA 98104 206.588.0256
ATOSSA THERAPEUTICS, INC. (Filer) CIK: 0001488039 (see all company filings)

EIN.: 264753208 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-248555 | Film No.: 201402634
SIC: 2834 Pharmaceutical Preparations